Diebold Nixdorf (DBD) Common Equity (2009 - 2026)

Diebold Nixdorf's Common Equity history runs 18 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• Quarterly Common Equity rose 3.22% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 3.22% YoY) and the FY2025 annual result came in at $1.1 billion, up 1100000.0% from the prior year.
• Common Equity was $1.0 billion for Q1 2026 at Diebold Nixdorf, down from $1.1 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.1 billion in Q3 2025 and bottomed at -$2.1 billion in Q2 2023.
• A 5-year average of -$69.8 million and a median of $800000.0 in 2024 frame the typical range for Common Equity.
• Peak annual rise in Common Equity reached 1100000.0% in 2025, while the deepest fall reached 187.5% in 2025.
• Diebold Nixdorf's Common Equity stood at -$1.4 billion in 2022, then surged by 176.72% to $1.1 billion in 2023, then sank by 100.01% to -$100000.0 in 2024, then soared by 1100000.0% to $1.1 billion in 2025, then dropped by 7.0% to $1.0 billion in 2026.
• Business Quant data shows DBD's Common Equity at $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.